Chalepensin behaves as an energy transfer inhibitor at low concentration, it inhibits multiple P450s and that epoxidation activity is crucial for the potential drug interaction through mechanism-based inhibition. Chalepensin shows antiprotozoal activity; it also can cause significant inhibition of radicle growth of A. hypochondriacus and E. crus-galli.

13164-03-9

C16H14O3

254.28

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years